0.8446
price down icon5.18%   -0.0461
after-market Dopo l'orario di chiusura: .87 0.0254 +3.01%
loading
Precedente Chiudi:
$0.8907
Aprire:
$0.8971
Volume 24 ore:
322.09K
Relative Volume:
1.28
Capitalizzazione di mercato:
$37.20M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-0.8121
EPS:
-1.04
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
+1.78%
1M Prestazione:
-18.00%
6M Prestazione:
-71.47%
1 anno Prestazione:
-87.49%
Intervallo 1D:
Value
$0.8121
$0.9105
Intervallo di 1 settimana:
Value
$0.8121
$0.9658
Portata 52W:
Value
$0.595
$6.89

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name
Nome
Werewolf Therapeutics Inc
Name
Telefono
617-952-0555
Name
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Name
Dipendente
46
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
HOWL's Discussions on Twitter

Confronta HOWL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
HOWL
Werewolf Therapeutics Inc
0.8446 37.20M 19.94M -37.37M -33.38M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-03 Iniziato JMP Securities Mkt Outperform
2023-08-24 Iniziato Wedbush Outperform
2023-06-06 Ripresa Jefferies Buy
2021-09-10 Iniziato BofA Securities Buy
2021-05-25 Iniziato Evercore ISI Outperform
2021-05-25 Iniziato H.C. Wainwright Buy
2021-05-25 Iniziato Jefferies Buy
2021-05-25 Iniziato SVB Leerink Outperform
Mostra tutto

Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie

pulisher
Apr 25, 2025

Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Friday - Defense World

Apr 25, 2025
pulisher
Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform By Investing.com - Investing.com India

Apr 21, 2025
pulisher
Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform - Investing.com

Apr 21, 2025
pulisher
Apr 17, 2025

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Cancer Drug Developer Werewolf Therapeutics Strengthens Leadership Team Amid Promising Clinical Results - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

Werewolf Therapeutics names Steven Bloom as CBO - The Pharma Letter

Apr 17, 2025
pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics Reveals Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Bank of New York Mellon Corp Grows Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 - Investing.com India

Mar 26, 2025
pulisher
Mar 18, 2025

Werewolf Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

HC Wainwright Issues Pessimistic Outlook for HOWL Earnings - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Wedbush Research Analysts Cut Earnings Estimates for HOWL - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Reaffirms Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Inc. (HOWL) reports earnings - Quartz

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c) - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - Bakersfield.com

Mar 11, 2025
pulisher
Mar 11, 2025

HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Mar 11, 2025
pulisher
Mar 04, 2025

Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

What Will Werewolf Therapeutics Reveal at the Leerink Biopharma Conference Next Month? - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Werewolf Therapeutics, Inc. Announces Board Changes and Committee Appointment - Marketscreener.com

Mar 01, 2025
pulisher
Feb 28, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 - Investing.com

Feb 27, 2025
pulisher
Feb 26, 2025

Werewolf Therapeutics Announces Board Resignation and New Appointment - Defense World

Feb 26, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Oncology Pioneer Transform Werewolf's Cancer-Fighting Platform? - StockTitan

Feb 24, 2025
pulisher
Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025
pulisher
Feb 11, 2025

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 11, 2025
pulisher
Feb 07, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - MarketBeat

Feb 07, 2025
pulisher
Jan 28, 2025

Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World

Jan 28, 2025
pulisher
Jan 24, 2025

Barclays PLC Increases Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jan 24, 2025
pulisher
Jan 19, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 13.2% in December - MarketBeat

Jan 19, 2025

Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Capitalizzazione:     |  Volume (24 ore):